Adipose Tissue, Regeneration, and Skin Health: The Next Regenerative Frontier.

Alan D Widgerow
Author Information

Abstract

Adipose tissue, or fat compartments, has long been considered a storage depot and an energy source. However, a large part of new research, starting with the discovery of adipose-derived stem cells, has redirected this thinking toward the tremendous regenerative capacity that adipose tissue possesses when it is healthy. This has resulted in multiple technologies being explored with fat as a basis or with fat as a target aiming at the stimulation of new small hyperplastic adipose cells exuding adipokines and encouraging the proliferation of a whole host of progenitor cells that can have positive effects on many organ systems. One of these organ systems is skin, and there is a direct correlation with various fat compartments and skin health. Dermal fat tissue, also known as dermal white adipose tissue, is one such compartment that originates from dermal preadipocytes transdifferentiating into adipocytes and progenitor adipose cells under the right cues. The author of this paper discusses these potential cues, including injectable fillers, fat grafts, and topical formulations, and their capacity to impact skin health through the generation of healthy fat tissue. In addition, small molecules such as glucagon-like peptide-1 peptides and their impact on fat tissue are discussed. Adipose tissue is being recognized as the next regenerative frontier with exciting prospects ahead.
Level of Evidence 5 Therapeutic:

References

  1. Clin Plast Surg. 2020 Jan;47(1):31-41 [PMID: 31739895]
  2. Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E634-43 [PMID: 20040695]
  3. J Plast Reconstr Aesthet Surg. 2020 Jun;73(6):1166-1173 [PMID: 32269011]
  4. Exp Dermatol. 2015 Dec;24(12):924-9 [PMID: 26194659]
  5. Aesthet Surg J. 2024 Oct 15;44(11):NP809-NP818 [PMID: 38874170]
  6. Mol Biol Rep. 2019 Feb;46(1):1459-1475 [PMID: 30484107]
  7. Biomol Ther (Seoul). 2022 May 1;30(3):221-231 [PMID: 34615771]
  8. Mol Cell Endocrinol. 2015 Feb 15;402:43-50 [PMID: 25575456]
  9. J Cosmet Dermatol. 2021 May;20(5):1474-1482 [PMID: 33150734]
  10. Sci Rep. 2016 May 10;6:25616 [PMID: 27161953]
  11. Cell Death Dis. 2024 Jun 24;15(6):443 [PMID: 38914551]
  12. J Drugs Dermatol. 2019 Apr 01;18(4):342-348 [PMID: 31012562]
  13. Lipids Health Dis. 2020 Oct 2;19(1):215 [PMID: 33008429]
  14. Surgery. 2015 Jan;157(1):1-5 [PMID: 25482459]
  15. J Invest Dermatol. 2023 Dec;143(12):2456-2467.e5 [PMID: 37295491]
  16. Plast Reconstr Surg. 2016 Aug;138(2):237e-247e [PMID: 27465185]
  17. Front Cell Dev Biol. 2021 Oct 15;9:728188 [PMID: 34722509]
  18. Ann Plast Surg. 2015 Mar;74(3):376-82 [PMID: 25643185]
  19. Aesthet Surg J Open Forum. 2021 Aug 07;3(3):ojab029 [PMID: 34476397]
  20. Clin Plast Surg. 2020 Jan;47(1):53-62 [PMID: 31739897]
  21. Aesthet Surg J Open Forum. 2020 Jul 03;2(3):ojaa033 [PMID: 33791656]
  22. J Invest Dermatol. 2019 May;139(5):1002-1009 [PMID: 30879642]
  23. Front Physiol. 2024 Feb 23;15:1346612 [PMID: 38465261]
  24. Int J Mol Sci. 2020 Nov 28;21(23): [PMID: 33260746]
  25. Aesthet Surg J Open Forum. 2020 Nov 18;3(1):ojaa052 [PMID: 33791673]
  26. Curr Issues Mol Biol. 2023 May 01;45(5):3829-3847 [PMID: 37232716]
  27. Exp Dermatol. 2014 Sep;23(9):629-31 [PMID: 24841073]
  28. Gels. 2023 Jul 28;9(8): [PMID: 37623069]
  29. J Cosmet Dermatol. 2019 Feb;18(1):176-182 [PMID: 29504212]
  30. J Invest Dermatol. 2018 Apr;138(4):811-825 [PMID: 29391249]
  31. Plast Reconstr Surg Glob Open. 2024 Jan 24;12(1):e5523 [PMID: 38268716]
  32. Plast Reconstr Surg. 2013 Oct;132(4):1017-1026 [PMID: 23783059]
  33. Biochim Biophys Acta. 2014 Mar;1842(3):340-51 [PMID: 23747579]
  34. Ann Med Surg (Lond). 2017 Jun 27;20:49-60 [PMID: 28702187]
  35. Cell Transplant. 2023 Jan-Dec;32:9636897231175968 [PMID: 37243545]
  36. Aesthet Surg J Open Forum. 2022 Jun 10;4:ojac054 [PMID: 35979375]
  37. Mol Metab. 2019 Dec;30:72-130 [PMID: 31767182]
  38. Aging (Albany NY). 2016 Jul;8(7):1457-69 [PMID: 27434510]
  39. Aesthet Surg J Open Forum. 2020 Dec 30;3(1):ojaa055 [PMID: 33791675]
  40. N Engl J Med. 2021 Mar 18;384(11):989-1002 [PMID: 33567185]
  41. Exp Dermatol. 2015 Dec;24(12):912-5 [PMID: 26309229]
  42. Nat Rev Endocrinol. 2018 Mar;14(3):163-173 [PMID: 29327704]
  43. J Lipid Res. 2015 Nov;56(11):2061-9 [PMID: 26405076]
  44. J Cell Physiol. 2022 Jan;237(1):169-177 [PMID: 34608987]
  45. J Invest Dermatol. 2011 Oct;131(10):2004-9 [PMID: 21697886]
  46. J Drugs Dermatol. 2019 Apr 01;18(4):375-380 [PMID: 31012732]
  47. Pharmacol Res. 2012 Dec;66(6):505-12 [PMID: 23017672]
  48. Aesthet Surg J Open Forum. 2020 Jan 14;2(1):ojz037 [PMID: 33791636]

Word Cloud

Created with Highcharts 10.0.0fattissuecellsadiposeAdiposeskincompartmentsnewregenerativecapacityhealthysmallprogenitororgansystemshealthdermalcuesimpactlongconsideredstoragedepotenergysourceHoweverlargepartresearchstartingdiscoveryadipose-derivedstemredirectedthinkingtowardtremendouspossessesresultedmultipletechnologiesexploredbasistargetaimingstimulationhyperplasticexudingadipokinesencouragingproliferationwholehostcanpositiveeffectsmanyOnedirectcorrelationvariousDermalalsoknownwhiteonecompartmentoriginatespreadipocytestransdifferentiatingadipocytesrightauthorpaperdiscussespotentialincludinginjectablefillersgraftstopicalformulationsgenerationadditionmoleculesglucagon-likepeptide-1peptidesdiscussedrecognizednextfrontierexcitingprospectsaheadLevelEvidence5Therapeutic:TissueRegenerationSkinHealth:NextRegenerativeFrontier

Similar Articles

Cited By

No available data.